Implant:
Contraindicated in:
Use Cautiously in:
CV: arrhythmias, bradycardia, CARDIOVASCULAR COLLAPSE, hypotension.
Derm: pruritus.
EENT: blurred vision, tinnitus.
F and E: metabolic acidosis.
GI: nausea, vomiting.
GU: urinary retention.
Hemat: methemoglobinemia.
Local: incision site swelling/pain (implant).
Neuro: anxiety, circumoral tingling/numbness, dizziness, dysgeusia, headache, irritability, SEIZURES, tremor.
Misc: fever, allergic reactions.
Drug-Drug:
(Generic available)
Absorption: Systemic absorption follows epidural administration, but amount absorbed depends on dose.
Distribution: If systemic absorption occurs, this agent is widely distributed and crosses the placenta.
Metabolism/Excretion: Small amounts that may reach systemic circulation are mostly metabolized by the liver; 6% excreted unchanged in the urine.
Half-life: 1.55 hr (after epidural use); 19 hr (implant).
(analgesia)
ROUTE | ONSET | PEAK | DURATION |
---|---|---|---|
Epidural | 1030 min | Unknown | 28 hr |
Implant | Unknown | Unknown | Unknown |
Duration of anesthetic block.
NDC Code*